LexDanaLexDanabeta
Inventor

James R. APGAR

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
C12NMicroorganisms or enzymes11%
C12YEnzymes11%
Y02ATechnologies for adaptation to climate change11%
PatentTitleYear
12,227,564Anti-GDF15 antibodies, compositions and methods of use202512,168,698Tissue factor pathway inhibitor antibodies and uses thereof202411,634,504Tissue factor pathway inhibitor antibodies and uses thereof202311,566,066Anti-GDF15 antibodies, compositions and methods of use2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to PFIZER (4)· patent assignee history
2023–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PFIZER42023–2025
Locations
LocationPatentsSpan
US42023–2025